FRP Medical Devices

FRP Medical Devices, a division of FRP Ltd. , specializes in the rapid development and production of medical devices, offering precision prototyping and scalable manufacturing solutions tailored to the healthcare sector. FRP Medical Devices focuses on providing manufacturing solutions for medical devices. Established in Wisbech, UK, it operates as a subsidiary of FRP Ltd.

The company has successfully closed 1 deal as of January 7, 2026, marking its strategic presence in the medical manufacturing sector. Fast Track Medical Manufacturing Solutions specializes in the rapid development and production of medical devices, focusing on precision prototyping, low-volume injection molding, and scalable manufacturing solutions. The core offerings include advanced prototyping techniques such as vacuum casting, allowing for quick and cost-effective creation of reliable models. The company excels in developing high-precision injectors and inhalers, ensuring compliance with stringent safety, quality, and regulatory standards.

Fast Track Medical serves clients in highly regulated markets, including North America and Europe, addressing the needs of medical device manufacturers, healthcare providers, and diagnostics developers. Fast Track Medical operates a B2B revenue model primarily involving direct transactions with medical device manufacturers and healthcare organizations. The company generates revenue through the sale of its manufacturing solutions, including prototyping, injection molding, and assembly. Partnerships usually involve project-based contracts, tailored to specific needs and timelines.

The pricing structure is based on production complexity and volume, ensuring competitive rates for both low-volume and full-scale manufacturing. Flagship offerings, such as precision injectors and inhalers, are integral to their revenue stream, attracting a diverse clientele within the medical devices sector. In January 2026, FRP Medical Devices was acquired by IGS GeboJagema, a portfolio company of BC Partners and smile invest, which allows IGS GeboJagema to expand its capabilities in the medical field. The acquisition is set to support future growth initiatives, including the launch of new products and potential expansions into new markets.